© 2023 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved. EMD Serono, Inc. is the healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada.
EMD Serono leverages our synergistic portfolio in three key areas:
Our curiosity drives us to transform the standard of care for challenging cancers.
DDR, DNA damage response; MET, mesenchymal epithelial transition factor.